Multiple system atrophy (MSA)
Would you like to receive a message when there is new research about Multiple System Atrophy (MSA)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Multiple System Atrophy (MSA). View what Premium costs.
Publications and studies (1551)
- Involuntary inspiratory sigh in multiple system atrophy: A clinical and cerebral blood flow study. (2026/10/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies. (2026/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Ludangshen oral liquid ameliorates cyclophosphamide-induced immunosuppression in mice: Insights from metabolomic, gut microbiota, and multi-omics correlation analyses. (2026/09/01) ♡
- Dual Dopaminergic and Limbic-Cognitive Contributions to Gait Parameters in De Novo Parkinson Disease. (2026/08/11) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial. (2026/08/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Prospects Are Looking Up for Treatment of Neurogenic Orthostatic Hypotension in Multiple System Atrophy. (2026/08/11) ♡
- Clinicopathologic mismatch in young-onset parkinsonism: Multiple system atrophy masquerading as a neurotransmitter synthesis disorder. (2026/08/10) ♡
- Nutritional Factors and Weight Loss Predict Tracheostomy-Free Survival in Multiple System Atrophy. (2026/08/07) ♡
- [Multiple system atrophy]. (2026/08/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Type 2 α-Synuclein Seed Amplification as a Diagnostic Reassessment Signal in Parkinson's Progression Markers Initiative Parkinson's Disease. (2026/08/06) ♡
- Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort study. (2026/08/05) ♡
- Patterns of iron deposition and classification in parkinsonian syndromes: a quantitative susceptibility mapping study. (2026/08/05) ♡
- Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases. (2026/08/05) ♡
- Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quantitative susceptibility mapping in neurodegenerative diseases: An umbrella review of iron-related biomarkers and mechanisms. (2026/08/03) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of Spirulina phycocyanin on Caco-2 cell injury and ulcerative colitis in mice. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Urodynamics and what they reveal about autonomic innervation of the lower urinary tract: A narrative review. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Acupuncture for erectile dysfunction in multiple system atrophy: a case report. (2026/08/01) ♡
- Lingual pressure as a physiological indicator for dysphagia in amyotrophic lateral sclerosis and multiple system atrophy. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of ginsenosides in obesity-associated sarcopenia: Focus on E3 ubiquitin ligase-mediated regulation of protein homeostasis. (2026/08/01) ♡
- Early and Divergent Lipid Mediator Remodelling in Fast Versus Slow Skeletal Muscles of Female hSOD1(G93A) Mice. (2026/08/01) ♡
- Decoding Prodromal Lewy Body Disease: Clinical Differences Between Isolated REM Sleep Behavior Disorder and Hyposmia With Dopamine Transporter Deficit. (2026/08/01) ♡
- Validation of orthostatic hypotension in MDS diagnostic criteria for multiple system atrophy. (2026/07/29) ♡
- Early assessment, diagnosis and treatment of Parkinsonism and Related Syndromes study (ExPRESS): a protocol for an observational study on incident parkinsonism. (2026/07/29) ♡
- Longitudinal Systemic Transcriptomic Profiling and Neuropathological Deposition of Neutrophil Extracellular Traps in Parkinson's Disease. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hippocampal remodeling in chronic pain: Structural, functional, cellular, metabolic, and molecular mechanisms and therapeutic perspectives. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple system atrophy: cure and care. (2026/07/25) ♡
- Pre-Diagnostic Factors Associated with Coding-Based Incident Multiple System Atrophy: A Nested Case-Control Study of the UK Biobank. (2026/07/25) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial for "Substantia Nigra Susceptibility-to-Volume Ratio Derived from QSM as a Marker for Discrimination of Progressive Supranuclear Palsy from Parkinson's Disease and Multiple System Atrophy". (2026/07/24) ♡
- Plasma LC-HRMS metabolomics in parkinsonian syndromes: comparative evaluation of sample preparation protocols for exploratory metabolic signatures. (2026/07/24) ♡
- Peripheral and central inflammation in progressive supranuclear palsy syndrome: an immunological and imaging neuroinflammation study. (2026/07/23) ♡
- Integrative multicohort analysis reveals consistent sex differences in gut microbiota of multiple sclerosis patients. (2026/07/22) ♡
- Attitudes in Patients With Prodromal and Overt α-Synucleinopathy Toward Risk Disclosure: A Nationwide Registry. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRI Correlates of Depression and Anxiety in Multiple Sclerosis. (2026/07/21) ♡
- Protein-First, but Not Protein-Only: Rethinking Neurodegenerative Diseases Through Transgenic Mouse Models. (2026/07/21) ♡
- Substantia Nigra Susceptibility-To-Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy. (2026/07/20) ♡
- Brain Morphological Alterations in Adults with Spinal Muscular Atrophy Types 2 and 3: A CAT12-Derived Region-Based and Surface-Based Morphometry Study. (2026/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Adult-Onset Alexander Disease Presenting as Atypical Parkinsonism and Autonomic Dysfunction: A Case Series. (2026/07/20) ♡
- Correction: GATD3A-mediated monocyte homeostasis and compartmentalized erythrocyte alpha-synuclein discriminate early Parkinson's disease from MSA-P. (2026/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond the brain: Polyglutamine disease pathology outside the nervous system. (2026/07/18) ♡
- Macular Features in X-Linked Retinoschisis Patients. (2026/07/18) ♡
- Choroidal thickness postural changes in healthy young adults. (2026/07/18) ♡
- Plasma Total and Phosphorylated α-Synuclein as Biomarkers in Multiple System Atrophy: A Multicenter Study. (2026/07/17) ♡
- Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease. (2026/07/16) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Injury and recovery patterns of the blood-testis barrier and spermatogenic function in a surgical unilateral cryptorchidism model in rats. (2026/07/16) ♡
- Development of an RNA aptamer as a therapeutic agent for synucleinopathies. (2026/07/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder. (2026/07/14) ♡
- Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure. (2026/07/13) ♡
- A single-domain antibody targets aggregation-prone region of α-synuclein to reduce synucleinopathy, rescue neurodegeneration and improve function. (2026/07/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.